In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Oligonucleotide, Nucleic Acid Probe), Technology (Immunoassay, Hematology, Microbiology), Use (Research, Analyte Specific Reagent), End User (IVD Manufacturer, Clinical Laboratory) – Global Forecast to 2027

  • Report ID:MRHC - 104414
  • Pages: 127
  • Jul 2020
  • Formats*: PDF
  • Category: Healthcare
  • Delivery: 2 to 4 Hours

1. Introduction
    1.1. Market Definition    
    1.2. Market Ecosystem 
    1.3. Currency
    1.4. Key Stakeholders 

2. Research Methodology
    2.1. Research Process
    2.2. Data Collection and Validation 
           2.2.1. Secondary Research
           2.2.2. Primary Research
    2.3. Market Assessment 
           2.3.1. Market Size Estimation
           2.3.2. Market Share Analysis
    2.4. Assumptions for the Study     
    2.5. Limitations for the Study 

3. Executive Summary

4. Market Insights
    4.1. Introduction
    4.2. Drivers
    4.3. Restraints
    4.4. Opportunities
    4.5. Challenges

5. IVD Reagents Market, by Technology 
    5.1. Introduction
    5.2. Immunoassay/Immunochemistry, by Application  
           5.2.1. Immunohistochemistry
           5.2.2. Immunoprecipitation
           5.2.3. Functional Assays 
           5.2.4. Immunofluorescence
           5.2.5. Western Blotting
           5.2.6. ELISA
           5.2.7. Other Applications
    5.3. Biochemistry/Clinical Chemistry 
    5.4. Molecular Diagnostics
    5.5. Microbiology 
    5.6. Hematology 
    5.7. Coagulation/Hemostasis 
    5.8. Urinalysis
    5.9. Other Technologies    

6. IVD Reagents Market, by Type 
    6.1. Introduction
    6.2. Oligonucleotides
    6.3. Antibodies
           6.3.1. Antibodies Market, by Type
                     6.3.1.1. Monoclonal
           6.3.1. Antibodies Market, by Type
                     6.3.1.2. Polyclonal
           6.3.2. Antibodies Market, by Target
           6.3.1. Antibodies Market, by Type
                    6.3.2.1. CD
                    6.3.2.2. TCR
                    6.3.2.3. EGFR
                    6.3.2.4. Others
    6.4. Nucleic Acid Probes
    6.5. Purified Proteins Or Peptides

7. Global IVD Reagents Market,  By Use 
    7.1. Introduction
    7.2. Research Use Only (RUO) 
    7.3. Analyte Specific Reagents
    7.4. Clinical Use 

8. IVD Reagents Market, By End User 
    8.1. Introduction
    8.2. IVD Manufacturers
    8.3. Clinical Laboratories
    8.4. Other End Users    

9. IVD Reagents Market, By Geography 
    9.1. Introduction
    9.2. North America
    9.3. Europe
    9.4. Asia Pacific
    9.5. Latin America
    9.6. Middle East And Africa     

10. IVD Reagents Market: Competitive Landscape
      10.1. Introduction
      10.2. Key Growth Strategies
      10.3. Competitive Benchmarking
      10.4. Market Share Analysis, by Key Player (2019) 

11. IVD Reagents Market: Company Profiles 
      11.1. Becton, Dickinson And Company
      11.2. Merck KGaA
      11.3. Abcam plc. 
      11.4. Bio-Techne Corporation
      11.5. The Binding Site Group Ltd
      11.6. LGC Biosearch Technologies    
      11.7. Lakepharma, Inc.
      11.8. Biolegend, Inc.
      11.9. Inbios International, Inc. 
      11.10. Bioline Meridian Bioscience
      11.11. SDIX, LLC
      11.12. Thermo fisher scientific Inc.
      11.13. Bio-rad laboratories, Inc.
      11.14. Hologic Inc.
      11.15. Agilent Technologies, Inc.
      11.16. Beckman coulter Inc.
      11.17. DIACLONE SAS
      11.18.  Bio-Synthesis Inc
      11.19. Raybiotech, Inc. 
      11.20. Sino Biological Inc. 

12. Appendix 
      12.1. Questionnaire 
      12.2. Available Customization 

List of Tables

Table 1 In-Vitro Diagnostic Reagents Market Drivers: Impact Analysis (2020-2027)
Table 2 In-Vitro Diagnostic Reagents Market Restraint: Impact Analysis (2020-2027)
Table 3 In-Vitro Diagnostic Reagents Market Size, by Type, 2018-2027 ($Million)
Table 4 Key Companies Offering Oligonucleotides for IVD 
Table 5 Oligonucleotides Market Size for IVD, by Country/Region, 2018-2027 ($ Million) 
Table 6 Antibodies Market Size for IVD, by Country/Region, 2018-2027 ($ Million) 
Table 7 Antibodies Market Size for IVD, By Type 2018-2027 
Table 8 Key Companies Offering Monoclonal Antibodies for IVD 
Table 9 Monoclonal Antibodies Market Size for IVD, by Country/Region, 2018-2027 ($ Million) 
Table 10 Key Companies Offering Polyclonal Antibodies for IVD 
Table 11 Polyclonal Antibodies Market Size for IVD, by Country/Region, 2018-2027 ($ Million) 
Table 12 Antibodies Market Size for IVD, by Target, 2018-2027 ($ Million)
Table 13 Key Companies Offering CD Antibodies for IVD 
Table 14 CD Antibodies Market Size for IVD, by Country/Region, 2018-2027 ($ Million) 
Table 15 Key Companies Offering TCR Antibodies for IVD 
Table 16 TCR Antibodies Market Size for IVD, by Country/Region, 2018-2027 ($ Million) 
Table 17 Key Companies Offering EGFR Antibodies for IVD 
Table 18 EGFR Antibodies Market Size for IVD, by Country/Region, 2018-2027 ($ Million) 
Table 19 Other Target Antibodies Market Size for IVD, by Country/Region, 2018-2027 ($ Million) 
Table 20 Key Companies Offering Nucleic Acid Probes for IVD 
Table 21 Nucleic Acid Probes Market Size for IVD, by Country/Region, 2018-2027 ($ Million) 
Table 22 Key Companies Offering Purified Proteins or Peptides for IVD 
Table 23 Purified Proteins or Peptides Market Size for IVD, by Country/Region, 2018-2027 ($ Million) 
Table 24 In-Vitro Diagnostic Reagents Market Size, by Technology 2018-2027 ($Million)
Table 25 Key Companies Offering IVD Reagents for Immunoassay Development 
Table 26 Key Companies Offering IVD Reagents for Clinical Use 
Table 27 Key Companies Offering ASR for Immunoassays
Table 28 IVD Reagents Market Size for Immunoassays/Immunochemistry, by Application, 2018-2027 ($Million)
Table 29 IVD Reagents Market Size for Immunoassays/Immunochemistry, by Country/Region, 2018-2027 ($ Million)
Table 30 IVD Reagents Market Size for ELISA, by Country/Region, 2018-2027 ($ Million)
Table 31 IVD Reagents Market Size for Western Blotting, by Country/Region, 2018-2027 ($ Million)
Table 32 IVD Reagents Market Size for Immunofluorescence, by Country/Region, 2018-2027 ($ Million)
Table 33 IVD Reagents Market Size for Immunohistochemistry, by Country/Region, 2018-2027 ($ Million)
Table 34 IVD Reagents Market Size for Functional Assays, by Country/Region, 2018-2027 ($ Million)
Table 35 IVD Reagents Market Size for Immunoprecipitation, by Country/Region, 2018-2027 ($ Million)
Table 36 IVD Reagents Market Size for Other Technologies, by Country/Region, 2018-2027 ($ Million)
Table 37 Key Companies Offering IVD Reagents for Biochemistry/Clinical Chemistry Assay Development 
Table 38 Key Companies Offering Biochemistry/Clinical Chemistry IVD Reagents for Clinical Use 
Table 39 IVD Reagents Market Size for Biochemistry/Clinical Chemistry, by Country/Region, 2018-2027 ($ Million)
Table 40 Key Companies Offering IVD Reagents for Molecular Diagnostics Assay Development 
Table 41 Key Companies Offering Molecular Diagnostics Reagents for Clinical Use 
Table 42 Key Companies Offering ASR for Molecular Diagnostics  
Table 43 IVD Reagents Market Size for Molecular Diagnostics, by Country/Region, 2018-2027 ($ Million)
Table 44 Key Companies Offering IVD Reagents for Microbiology Assay Development 
Table 45 IVD Reagents Market Size for Microbiology, by Country/Region, 2018-2027 ($ Million)
Table 46 Key Companies Offering IVD Reagents for Hematology 
Table 47 IVD Reagents Market Size for Hematology, by Country/Region, 2018-2027 ($ Million)
Table 48 Key Companies Offering IVD Reagents for Coagulation/Hemostasis  
Table 49 IVD Reagents Market Size for Coagulation/Hemostasis, by Country/Region, 2018-2027 ($ Million)
Table 50 Key Companies Offering IVD Reagents for Urinalysis
Table 51 IVD Reagents Market Size for Urinalysis, by Country/Region, 2018-2027 ($ Million)
Table 52 IVD Reagents Market Size for Other Technologies, by Country/Region, 2018-2027 ($ Million)
Table 53 In-Vitro Diagnostic Reagents Market Size, by Use, 2018-2027 ($Million)
Table 54 IVD Reagents Market Size for Research Use, by Country/Region, 2018-2027 ($ Million)
Table 55 IVD Reagents Market Size for Clinical Use, by Country/Region, 2018-2027 ($ Million)
Table 56 IVD Reagents Market Size for ASR, by Country/Region, 2018-2027 ($ Million)
Table 57 In-Vitro Diagnostic Reagents Market Size, by End User, 2018-2027 ($Million)
Table 58 IVD Reagents Market Size for IVD Manufacturers, by Country/Region, 2018-2027 ($ Million)
Table 59 IVD Reagents Market Size for Clinical Laboratories, by Country/Region, 2018-2027 ($ Million)
Table 60 IVD Reagents Market Size for Other End Users, by Country/Region, 2018-2027 ($ Million)
Table 61 In-Vitro Diagnostic Reagents Market Size, by Region, 2018-2027 ($Million)
Table 62 North America: IVD Reagents Market Size, by Type, 2018-2027 ($Million)
Table 63 North America: IVD Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 64 North America: IVD Antibodies Market Size, by Target, 2018-2027 ($Million)
Table 65 North America: IVD Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 66 North America: Immunoassay/Immunochemistry IVD Reagents Market Size, by Type 2018-2027 ($Million)
Table 67 North America: IVD Reagents Market Size, by Use, 2018-2027 ($Million)
Table 68 North America: IVD Reagents Market Size, by End User, 2018-2027 ($Million)
Table 69 Europe: IVD Reagents Market Size, by Type, 2018-2027 ($Million)
Table 70 Europe: IVD Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 71 Europe: IVD Antibodies Market Size, by Target, 2018-2027 ($Million)
Table 72 Europe: IVD Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 73 Europe: Immunoassay/Immunochemistry IVD Reagents Market Size, by Type 2018-2027 ($Million)
Table 74 Europe: IVD Reagents Market Size, by Use, 2018-2027 ($Million)
Table 75 Europe: IVD Reagents Market Size, by End User, 2018-2027 ($Million)
Table 76 Asia-Pacific:  IVD Reagents Market Size, by Type, 2018-2027 ($Million)
Table 77 Asia-Pacific:  IVD Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 78 Asia-Pacific:  IVD Antibodies Market Size, by Target, 2018-2027 ($Million)
Table 79 Asia-Pacific:  IVD Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 80 Asia-Pacific:  Immunoassay/Immunochemistry IVD Reagents Market Size, by Type 2018-2027 ($Million)
Table 81 Asia-Pacific:  IVD Reagents Market Size, by Use, 2018-2027 ($Million)
Table 82 Asia-Pacific:  IVD Reagents Market Size, by End User, 2018-2027 ($Million)
Table 83 Latin America:  IVD Reagents Market Size, by Type, 2018-2027 ($Million)
Table 84 Latin America:  IVD Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 85 Latin America:  IVD Antibodies Market Size, by Target, 2018-2027 ($Million)
Table 86 Latin America:  IVD Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 87 Latin America:  Immunoassay/Immunochemistry IVD Reagents Market Size, by Type 2018-2027 ($Million)
Table 88 Latin America:  IVD Reagents Market Size, by Use, 2018-2027 ($Million)
Table 89 Latin America:  IVD Reagents Market Size, by End User, 2018-2027 ($Million)
Table 90 Middle East & Africa:  IVD Reagents Market Size, by Type, 2018-2027 ($Million)
Table 91 Middle East & Africa:  IVD Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 92 Middle East & Africa:  IVD Antibodies Market Size, by Target, 2018-2027 ($Million)
Table 93 Middle East & Africa:  IVD Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 94 Middle East & Africa: Immunoassay/Immunochemistry IVD Reagents Market Size, by Type 2018-2027 ($Million)
Table 95 Middle East & Africa:  IVD Reagents Market Size, by Use, 2018-2027 ($Million)
Table 96 Middle East & Africa:  IVD Reagents Market Size, by End User, 2018-2027 ($Million)
Table 97 Recent Developments, by Company, 2017-2020

List of Figures

Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Global In-Vitro Diagnostic Reagents Market, by Type, 2020 VS. 2027 ($Million)
Figure 8 Global In-Vitro Diagnostic Reagents Market, by Technology 2020 VS. 2027 ($Million)
Figure 9 Global In-Vitro Diagnostic Reagents Market, by Use 2020 VS. 2027 ($Million)
Figure 10 Clinical Laboratories are expected to dominate the IVD Reagents Market, by End User (2020-2027)
Figure 11 Global In-Vitro Diagnostic Reagents Market, by Region 
Figure 12 Market Dynamics 
Figure 13 Global In-Vitro Diagnostic Reagents Market Size, by Technology, 2020-2027 ($Million)
Figure 14 Global In-Vitro Diagnostic Reagents Market Size, by Type, 2020-2027 ($Million)
Figure 15 Global In-Vitro Diagnostic Reagents Market Size, by Use, 2020-2027 ($Million)
Figure 16 Global In-Vitro Diagnostic Reagents Market Size, by End User, 2020-2027 ($Million)
Figure 17 Global In-Vitro Diagnostic Reagents Market Size, by Geography, 2020-2027 ($Million)
Figure 18 North America: In-Vitro Diagnostic Reagents Market Snapshot
Figure 19 Europe: In-Vitro Diagnostic Reagents Market Snapshot
Figure 20 Asia-Pacific: In-Vitro Diagnostic Reagents Market Snapshot
Figure 21 Latin America: In-Vitro Diagnostic Reagents Market Snapshot
Figure 22 Middle East & Africa: In-Vitro Diagnostic Reagents Market Snapshot
Figure 23 Key growth strategies adopted by leading players, 2017-2020
Figure 24 In-Vitro Diagnostic Reagents Market: Competitive Benchmarking 
Figure 25 Market Share Analysis: In-Vitro Diagnostic Reagents Industry, 2019

COVID-19

This report provides pre & post COVID-19 market estimates

Download sample here

The in-vitro diagnostic reagents market is expected to reach $77.6 billion by 2027, at a CAGR of 7% during the forecast period of 2020 to 2027. Increasing global prevalence of acute and chronic infectious diseases coupled with rising geriatric population, increasing adoption of flow cytometry techniques in research and academia, increase in funding for research activities, and rising proteomics and genomics research studies are the key factors driving the growth of the IVD reagents market. In addition, the growing demand for protein therapeutics and personalized medicines and the emerging economies are expected to create lucrative opportunities for players operating in this market.

Impact of COVID-19 on IVD Reagents Market

COVID-19 pandemic has adversely hit many economies around the globe. The pandemic has affected more than 100 countries infecting more than 15,012,731 people and killing  619,150 as of 22nd July 2020 (Source: WHO). As a measure to control the spread of this disease and avoid related severe consequences, governments across the globe have announced partial or complete lockdown, which has majorly impacted many manufacturing and service industries. In this global pandemic, although many dedicated healthcare professionals work tirelessly on the frontlines to fight against this crisis, it’s equally important to minimize the spread of disease by preparing kits for early diagnosis. Testing is one of the greatest tools in understanding and managing the coronavirus pandemic. In response to the growing COVID-19 pandemic and shortages of laboratory-based molecular testing capacity and reagents, multiple diagnostic test manufacturers have developed and begun selling various assays & kits prepared using the IVD reagents. These simple test kits are based either on detection of proteins from the COVID-19 virus in respiratory samples (e.g. sputum, throat swab) or detection, in blood or serum, of human antibodies generated in response to infection. Thus, the pandemic has increased the adoption of IVD reagents for kits and assay preparation using immunoassay and molecular diagnostics technology.

                                                         Click here to: Get Free Sample Pages of this Report

Increase in the funding for research activities is propelling the growth of the  IVD reagents market

The R&D activities in academic institutes and government research institutes have significantly increased in the last 2-3 decades with rising funding from various government organizations driven by rising health care concern globally, complexity of clinical trials, and higher failure of drugs in earlier phase studies. In the U.S., the government R&D spending agencies such as Department of Defense (DOD), National Institutes of Health (NIH), Department of Energy (DOE), and National Aeronautics and Space Administration (NASA) account for 90% of the total R&D investments, globally. The National Institutes of Health (NIH) is the largest source of funding for basic and applied research in the world, providing approximately 84% of NIH funds to universities, medical schools, and other research institutes. In addition to this, according to WHO, it has been projected that, by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide with number of people with diabetes will increase by 2.5-fold in 2020.

Thus, the increased complexities and mortality rate due to diseases such as COVID-19, cardiovascular diseases, diabetes, cancers, and chronic respiratory diseases fuels the funding for research, ultimately driving the growth of the IVD reagents market.

Key Findings in the Global IVD Reagents Market Study:

Immunoassay/immunochemistry segment to dominate the IVD reagents market in 2020

The immunoassay/immunochemistry segment is estimated to dominate the IVD reagents market in 2020. Advantages offered by the segment like inherent specificity, high-throughput, high sensitivity, and low cost are driving the growth of this technology segment. Further, the increasing use of immunoassays in POC & infectious disease testing, development of novel tests, and rising demand for immunoassay-based tests are driving the growth of this market.

Antibodies segment to dominate the IVD reagents market in 2020  

The antibodies segment is estimated to dominate the overall IVD reagents market in 2020. The large share of this segment is mainly attributed to the widespread application of antibodies in medicine for the purpose of research, diagnosis, drug & IVD development, and disease treatment. In addition, the increasing proteomics & genomics-based research, funding for R&D, and rising need for disease specific biomarkers expands the use of antibodies in the IVD industry.

Asia Pacific: The fastest growing market

At regional level, IVD reagents market is estimated to be dominated by the North America in 2020, while, Asia Pacific region is expected to grow at the fastest CAGR during the forecast period. The factors driving the growth of Asia Pacific IVD reagents market are rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, rising need to manage growing burden of infectious diseases, growing accessibility to healthcare services & advanced products, growing income levels of middle-class population, and increasing number of hospitals and clinics.

Key Players

The report includes competitive landscape based on the extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments adopted by the leading market players in the industry over the past 4 years (2017-2020). The key players profiled in the global IVD reagents market are Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), LGC Biosearch Technologies (U.K.), BioLegend, Inc. (U.S.), InBios International, Inc. (U.S.), LakePharma, Inc. (U.S.), Bioline (U.K.), Abcam plc (U.K.), The Binding Site Group Ltd.(U.K.), SDIX, LLC (U.S.), DIACLONE SAS (France), Bio-Techne Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Hologic Inc. (U.S.), Bio-Synthesis Inc. (U.S.), RayBiotech, Inc. (U.S.), and Sino Biological Inc. (China).

Scope of the Report:

IVD Reagents Market, by Technology

  • Immunoassay/Immunochemistry
  • Biochemistry/Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Hematology
  • Coagulation/Hemostatis
  • Other technologies
    (Other Technologies comprises of hybridization and loop-mediated isothermal amplification)

IVD Reagents Market, by Type

  • Antibodies
  • Oligonucleotides
  • Nucleic Acid Probes
  • Purified Proteins or Peptides
  • Other Reagents
    (Other reagents include Blocking Agents, Detergents, Surfactants, Wetting Agents, Buffers, Stabilizers, Purified Water, Dyes, Standards & Controls, Enzymes, Cell Culture Reagents, and Anti-coagulants)

IVD Reagents Market, by Use

  • Research Use Only
  • Analyte Specific Reagents
  • Clinical Use

IVD Reagents Market, by End Users

  • IVD Manufacturers
  • Clinical Laboratories
  • Other End Users
    (Other end-users comprise of academic & research institutes, and hospital laboratories)

IVD Reagents Market, by Geography

  • North America
  • Europe
  • Asia-Pacific (APAC)
  • Latin America
  • Middle East & Africa

Key questions answered in the report:

The IVD reagents market covers the market size & forecasts of the IVD reagents like the oligonucleotides, antibodies, nucleic acid probes, purifies proteins & peptides, and other reagents. The IVD reagents market studied in this report involves the revenue analysis of various segments and sub segments of IVD reagents at regional and country level.
Based on the type, the antibodies segment is estimated to command the largest share of the overall IVD reagents market in 2020. However, the oligonucleotides segment is expected to grow at the fastest CAGR during the forecast period.
Based on the technology, the immunoassay/immunochemistry segment is projected to create more traction owing to the advantages offered by the segment like the inherent specificity, high-throughput, high sensitivity, and low cost are driving the growth of this technology segment. Further, the increasing use of immunoassays in POC & infectious disease testing, development of novel tests, and rising demand for immunoassay-based tests are the other key factors driving the growth of this market.
Increasing global prevalence of acute and chronic infectious diseases coupled with rising geriatric population, increasing adoption of flow cytometry techniques in research and academia, increased funding for research activities, and rising proteomics and genomics research studies are the key drivers of this market. However, the growing demand for protein therapeutics and personalized medicines and emerging economies are expected to create lucrative opportunities for players operating in this market.
The key players operating in the global IVD reagents market are Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), LGC Biosearch Technologies (U.K.), BioLegend, Inc. (U.S.), InBios International, Inc. (U.S.), LakePharma, Inc. (U.S.), Bioline (U.K.), Abcam plc (U.K.), The Binding Site Group Ltd.(U.K.), SDIX, LLC (U.S.), DIACLONE SAS (France), Bio-Techne Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Hologic Inc. (U.S.), Bio-Synthesis Inc. (U.S.), RayBiotech, Inc. (U.S.), and Sino Biological Inc. (China) among others
The emerging countries from Asia and Latin America are projected to offer significant growth opportunities for the vendors operating in this market due to rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, growing infectious diseases, and growing accessibility to healthcare services & advanced products.
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare Medical Technologies
Download Free Sample